Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Income from Continuing Operations (2016 - 2025)

Fortress Biotech has reported Income from Continuing Operations over the past 13 years, most recently at 5515000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 5515000.0 for Q4 2025, up 79.03% from a year ago — trailing twelve months through Dec 2025 was 54366000.0 (up 53.13% YoY), and the annual figure for FY2025 was 33037000.0, up 72.66%.
  • Income from Continuing Operations for Q4 2025 was 5515000.0 at Fortress Biotech, down from 8827000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for FBIO hit a ceiling of 8827000.0 in Q3 2025 and a floor of 62330000.0 in Q4 2021.
  • Median Income from Continuing Operations over the past 5 years was 35842000.0 (2024), compared with a mean of 35524750.0.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 159.57% in 2021 and later skyrocketed 133.07% in 2025.
  • Fortress Biotech's Income from Continuing Operations stood at 62330000.0 in 2021, then grew by 7.92% to 57396000.0 in 2022, then soared by 49.89% to 28759000.0 in 2023, then increased by 8.54% to 26303000.0 in 2024, then skyrocketed by 79.03% to 5515000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 5515000.0 (Q4 2025), 8827000.0 (Q3 2025), and 35851000.0 (Q2 2025) per Business Quant data.